[1]陈雨菡,马善波,杨 倩,等.黄芪-丹参药对治疗缺血性脑卒中研究进展[J].陕西中医,2021,(8):1142-1146.[doi:DOI:10.3969/j.issn.1000-7369.2020.08.038]
　CHEN Yuhan,MA Shanbo,YANG Qian,et al.Therapeutic effect of Astragali-Salvia miltiorrhiza for ischemic stroke[J].,2021,(8):1142-1146.[doi:DOI:10.3969/j.issn.1000-7369.2020.08.038]
点击复制

黄芪-丹参药对治疗缺血性脑卒中研究进展
分享到：

《陕西中医》[ISSN:1000-7369/CN:61-1281/TN]

卷:
期数:
2021年8期
页码:
1142-1146
栏目:
综 述
出版日期:
2021-08-05

文章信息/Info

Title:
Therapeutic effect of Astragali-Salvia miltiorrhiza for ischemic stroke
作者:
陈雨菡1; 2; 马善波2; 杨 倩1; 2; 李 龙2; 王 锦2; 缪 珊2; 石小鹏1; 2
(1.陕西中医药大学,陕西 咸阳 712046; 2.空军军医大学西京医院药剂科,陕西 西安 710032)
Author(s):
CHEN Yuhan; MA Shanbo; YANG Qian; LI Long; WANG Jin; MIAO Shan; SHI Xiaopeng
(Shaanxi University of Chinese Medicine,Xianyang 712046,China)
关键词:
缺血性脑卒中;  黄芪;  丹参;  有效组分;  气虚血瘀
Keywords:
Cerebral ischemic stroke;  Astragalus;  Salvia miltiorrhiza;  Effective components;  Qi deficiency and blood stasis
分类号:
R 743
DOI:
DOI:10.3969/j.issn.1000-7369.2020.08.038
文献标志码:
A
摘要:
脑卒中,中医俗称“中风”,是致人死亡的主要原因之一,其分为缺血性和出血性两类。中医认为“气虚血瘀” 是缺血性脑卒中的主要病机,“气虚”是发病之本,“血瘀”乃病发展之核心。急性缺血性脑卒中会导致血-脑屏障破坏、神经元坏死、细胞毒性以及血管源性水肿、炎性反应等。临床实践表明,黄芪-丹参是中药治疗缺血性脑卒中的重要药对,且使用频率位于前列,临床疗效较好。研究发现黄芪-丹参药对中,黄芪具有抗凋亡、抗炎、扩张血管、改善血行的作用,丹参能增加微循环血流量,明显减轻脑水肿,从而保护脑细胞。黄芪、丹参不管是进行有效组分配伍还是药对直接进行配伍,不仅对于急性缺血性脑卒中疗效显著,还可以缓解脑缺血再灌注损伤,且对于预后作用明显,两药相辅相成,有望成为治疗缺血性脑卒中的理想药物。
Abstract:
Stroke,commonly known as “stroke” in traditional Chinese medicine,is one of the main causes of death,which can be divided into two categories:ischemic and hemorrhagic.Traditional Chinese medicine believes that “Qi deficiency and blood stasis” is the main pathogenesis of ischemic stroke,“Qi deficiency” is the root of the disease,and “blood stasis” is the core of the development of the disease.Acute ischemic stroke can lead to destruction of blood-brain barrier,neuronal necrosis,cytotoxicity,angiogenic edema,inflammatory reaction and so on.Clinical practice shows that Radix Astragali-Salvia miltiorrhiza is an important pair of traditional Chinese medicine in the treatment of ischemic stroke,and the frequency is in the forefront,and the clinical effect is significant.The study found that Radix Astragali-Salvia miltiorrhiza has the effects of anti-apoptosis,anti-inflammation,dilating blood vessels and improving blood flow.Radix Salviae Miltiorrhizae can increase microcirculatory blood flow and significantly reduce brain edema,thus protecting brain cells.Radix Astragali and Salvia miltiorrhiza,whether they are compatible with effective components or directly,can not only have a significant effect on acute ischemic stroke,but also alleviate cerebral ischemia-reperfusion injury,and play an obvious role in the prognosis of patients.The two drugs complement each other.It is expected to become an ideal drug for the treatment of ischemic stroke.

参考文献/References:

[1] 王陇德,刘建民,杨 弋,等.我国脑卒中防治仍面临巨大挑战—《中国脑卒中防治报告2018》概要[J].中国循环杂志,2019,34(2):6-20.
[2] 王宝艳,刘 刚,刘永宏,等.缺血性脑血管疾病发病相关因素调查研究[J].陕西医学杂志,2018,47(9):1210-1212.
[3] 曹 霞,裴 丽.中风相关病名古文献考略[J].中国医药导报,2018,15(12):132-134.
[4] 桂军明,朱守斌,张国旗,等.活血通络汤治疗痰瘀阻络型缺血性脑卒中临床研究[J].陕西中医,2020,41(8):1066-1069.
[5] 谢丽华,赵毅锦,林兴丽,等.中药治疗脑缺血的用药规律研究[J].中医药导报,2017,23(17):38-40.
[6] 袁清洁,王嘉麟,贺立娟,等.补阳还五汤治疗缺血性中风疗效机制研究进展[J].环球中医药,2017,10(12):1537-1542.
[7] 马 婧,陈 茜,边亚倩,等.基于系统中药学的丹参活血化瘀功效标志物研究[J].中国中药杂志,2020,45(14):3259-3265.
[8] 陈家权,李长生,杨晓妮.化瘀克塞方对急性脑梗死患者神经元特异性烯醇化酶变化的影响[J].上海中医药杂志,2009,43(3):17-19.
[9] 姜德远.黄芪丹参汤治疗脑梗死恢复期的临床疗效及炎性因子水平的影响[J].中国中医药现代远程教育,2018,16(5):99-100.
[10] 刘金栋.黄芪、丹参合用治疗急性脑梗死的疗效观察[J].世界最新医学信息文摘,2016,16(85):164.
[11] 崔 伟,王高频,卢美丽,等.黄芪甲苷通过激活PI3K/AKT通路抑制内皮细胞内质网应激介导的细胞凋亡的研究[J].中药药理与临床,2018,34(5):39-44.
[12] Tang H,Pan CS,Mao XW,et al.Role of NADPH oxidase in total salvianolic acid injection attenuating ischemia-reperfusion impaired cerebral microcirculation and neurons:implication of AMPK/Akt/PKC[J].Micro Circulation,2014,21(7):615-627.
[13] Yan FD,He SH.GW25-e0544 effects of salvianolic acid on proliferation,adhesion and NO secretion activity of human peripheral endothelial progenitor cells[J].J Am Coll Cardiol,2014,64(16):35.
[14] 李军昌,司静文,刘海涛,等.黄芪甲苷Ⅳ对梗死小鼠心肌新生血管成熟及HIF-1α、VEGF蛋白表达的影响[J].心脏杂志,2017,29(3):269-275.
[15] Liang C,Ni GX,Shi XL,et al.Astragaloside Ⅳ regulates the HIF/VEGF/Notch signaling pathway through miRNA-210 to promote angiogenesis after ischemic stroke[J].Restor Neurol Neurosci,2020,38(3):271-282.
[16] 赵先锋,徐 予.丹酚酸B促进内皮祖细胞动员和黏附的作用[J].中国组织工程研究,2017,21(21):3352-3357.
[17] 李耀汝.注射用丹参多酚酸通过JAK2/STAT3信号通路促进脑缺血小鼠血管生成及改善行为功能[D].石家庄:河北医科大学,2015.
[18] Li Y,Zhang X,Cui L,et al.Salvianolic acids enhance cerebral angiogenesis and neurological recovery by activating JAK2/STAT3 signaling pathway after ischemic stroke in mice[J].J Neurochem,2017,143(1):87-99.
[19] 王新东,卞 勇,祁晓霞.黄芪丹参水煎液激活AMPK上调自噬抑制ISO诱导的大鼠心肌重构[J].中药材,2017,40(10):2433-2436.
[20] 田 露,孔 旋,刘 俊,等.黄芪丹参不同配伍对气虚血瘀模型大鼠血液流变学和血管内皮因子的影响[J].现代生物医学进展,2017,17(9):1643-1647.
[21] 何菊芳,李婷婷,孙晓运,等.氧化应激及炎性反应与缺血性脑卒中的关系[J].武警医学,2016,27(12):1234-1236.
[22] 卢岚英,李 敏,谢 军,等.黄芪甲苷对大鼠局灶性脑缺血再灌注损伤的保护作用[J].药学服务与研究,2017,17(5):392-396.
[23] 王振富,杨付明.黄芪多糖对大鼠全脑缺血再灌注损伤的保护作用[J].中国老年学杂志,2016,36(5):1059-1060.
[24] Xu Z,Liu W,Huang H.Astragaloside Ⅳ alleviates cerebral ischemia-reperfusion injury by activating the janus kinase 2 and signal transducer and activator of transcription 3 signaling pathway[J].Pharmacology,2020,105(3-4):181-189.
[25] 孙瑞坦,朴翔宇,蔡 鸣,等.丹参多酚酸治疗局灶性脑缺血再灌注损伤大鼠对神经行为及因子水平的影响[J].海南医学院学报,2019,25(14):1057-1060.
[26] 闫莹莹,王岐鸣,徐长水.丹参多酚酸对脑缺血大鼠氧化应激的影响[J].河南医学研究,2019,28(5):773-776.
[27] 王建峰,张晨红,王 婉.缺血性脑血管病相关危险因素分析和治疗后疗效观察[J].陕西医学杂志,2017,46(12):1765-1766.
[28] Fan Y,Luo Q,Wei J,et al.Mechanism of salvianolic acid B neuroprotection against ischemia/reperfusion induced cerebral injury[J].Brain Res,2018,1679(15):125-133.
[29] 张建平,石 军,将来时,等.补阳还五汤联合依达拉奉注射液治疗脑卒中疗效观察[J].陕西中医,2017,38(10):1376-1377.
[30] 柳卫芳,昝小玲,黄 宁,等.依诺肝素联合黄芪莪术丹参方治疗失代偿期肝硬化合并门静脉系统血栓形成疗效及对凝血纤溶功能的影响[J].现代中西医结合杂志,2020,24(10):2667-2671.
[31] 黄志恩,李茹冰,姚 晖,等.补阳还五汤对急性脑缺血大鼠血清CD63和CD62P因子表达的影响[J].中成药,2016,38(4):735-740.
[32] 华晓东,税凤春,徐 琳,等.生物标志物检测法评价注射用丹参多酚酸对血小板活性的影响[J].中国药品标准,2019,20(2):110-114.
[33] Liu L,Li J,Zhang Y,et al.Salvianolic acid B inhibits platelets as a P2Y12 antagonist and PDE inhibitor:Evidence from clinic to laboratory[J].Thromb Res,2014,134(4):866-876.
[34] 杜冠华,王海港,宋俊科,等.心脑缺血的防治策略与丹参及丹酚酸A的作用与机制[J].中国药理学与毒理学杂志,2019,33(9):648-649.
[35] 曲友直,杨 震,李 敏,等.黄芪甲苷对脑缺血再灌注后血脑屏障的保护作用及IL-1β含量、MMP-9蛋白表达的影响[J].卒中与神经疾病,2016,23(6):389-391.
[36] Megra BW,Eugenin EA,Berman JW.Inflammatory mediators reduce surface PrPc on human BMVEC resulting in decreased barrier integrity[J].Lab Invest,2018,98(10):1347-1359.
[37] Aslam M,Ahmad N,Srivastava R,et al.TNFalpha induced NF-κB signaling and p65(RelA)overexpression repress Cldn5promoter in mouse brain endothelial cells[J].Cytokine,2012,57(2):269-275.
[38] Wu Q,Yuan X,Li B,et al.Salvianolic acid alleviated blood-brain barrier permeability in spontaneously hypertensive rats by inhibiting apoptosis in pericytes via P53 and the Ras/Raf/MEK/ERKpathway[J].Drug Des Devel Ther,2020,14(17):1523-1534.
[39] 宋俊科,杜冠华.丹酚酸A通过激活Nrf2抗氧化通路同时抑制MMP-9保护血脑屏障共同发挥抗脑缺血再灌注损伤作用[J].中国药理学与毒理学杂志,2019,33(10):868.

相似文献/References:

[1]耿银龙,张伟萍,任梦诗.温阳复元方对缺血性脑卒中患者运动功能及生存质量影响研究*[J].陕西中医,2020,(2):172.
　GENG Yinlong,ZHANG Weiping,REN Mengshi..Effect of Wenyang Fuyuan decoction on motor function and quality of life in patients with ischemic stroke[J].,2020,(8):172.
[2]杨 倩,屈 云,王凤英△.脊柱推拿联合康复治疗对缺血性脑卒中患者手功能的影响*[J].陕西中医,2020,(11):1580.[doi:DOI:10.3969/j.issn.1000-7369.2020.11.017]
　YANG Qian,QU Yun,WANG Fengying..Effect of spinal massage combined with routine rehabilitation therapy on recovery from hand dysfunction after ischemic stroke[J].,2020,(8):1580.[doi:DOI:10.3969/j.issn.1000-7369.2020.11.017]
[3]徐亚辉,才丽娜,贺大权,等.活血复健汤治疗脑卒中疗效及对患者神经功能与血清相关指标的影响*[J].陕西中医,2020,(11):1615.[doi:DOI:10.3969/j.issn.1000-7369.2020.11.026]
　XU Yahui,CAI Li'na,HE Daquan,et al.The effect of Huoxue Fujian decoction on cerebral apoplexy and its related indexes of nerve function and serum[J].,2020,(8):1615.[doi:DOI:10.3969/j.issn.1000-7369.2020.11.026]
[4]张锡萍,张斐雪,郑书林,等.血栓通联合吡拉西坦对缺血性脑卒中患者中医证候评分、神经功能及血清NPY、Hcy水平的影响[J].陕西中医,2021,(3):326.[doi:DOI:10.3969/j.issn.1000-7369.2020.03.014]
　ZHANG Xiping,ZHANG Feixue,ZHENG Shulin,et al.Influence of Xueshuantong combined with piracetam on TCM syndrome score neurological function and serum NPY and Hcy in patients with cerebral ischemic stroke[J].,2021,(8):326.[doi:DOI:10.3969/j.issn.1000-7369.2020.03.014]
[5]吕鸿燕,严兴亚,李 凤,等.缺血性脑卒中患者中医证型与Crouse积分、血清同型半胱氨酸、凝血功能相关性研究[J].陕西中医,2021,(7):879.[doi:DOI:10.3969/j.issn.1000-7369.2020.07.017]
　LYU Hongyan,YAN Xingya,LI Feng,et al.Correlation between TCM syndromes and Crouse score,serum Hcy,coagulation function in patients with ischemic stroke[J].,2021,(8):879.[doi:DOI:10.3969/j.issn.1000-7369.2020.07.017]
[6]倪广晓,段春巧,周宏斌,等.基于BDNF-Trk B信号通路探讨和血生络方对脑缺血大鼠认知功能的影响及机制研究[J].陕西中医,2021,(11):1481.[doi:DOI:10.3969/j.issn.1000-7369.2020.11.001]
　NI Guangxiao,DUAN Chunqiao,ZHOU Hongbin,et al.Investigated effect of Hexue Shengluo decoction on cognitive function in MCAO rats and mechanism based on BDNF-Trk B signaling pathway[J].,2021,(8):1481.[doi:DOI:10.3969/j.issn.1000-7369.2020.11.001]
[7]李 芮,刘 健,靳 楠,等.基于网络药理学探讨当归补血汤治疗再生障碍性贫血作用机制[J].陕西中医,2022,(3):384.[doi:DOI:10.3969/j.issn.1000-7369.2022.03.028]
[8]王少琴,刘丽彬.子午流注纳子法结合温通针法对缺血性脑卒中患者下肢肢体功能康复及脑血流水平的影响[J].陕西中医,2022,(4):523.[doi:DOI:10.3969/j.issn.1000-7369.2022.04.029]
　WANG Shaoqin,LIU Libin.Effects of Ziwu Liuzhu Nazi method combined with Wentong acupuncture method on lower limb function and cerebral blood flow in patients with ischemic stroke[J].,2022,(8):523.[doi:DOI:10.3969/j.issn.1000-7369.2022.04.029]
[9]吴玉杰,石小平,孙丽曼.针灸联合黄芪对冠心病心绞痛患者血清正五聚蛋白-3、可溶性CD40L水平的影响[J].陕西中医,2022,(5):644.[doi:DOI:10.3969/j.issn.1000-7369.2022.05.024]
　WU Yujie,SHI Xiaoping,SUN Liman.The effect of acupuncture and moxibustion combined with astragalus on the levels of PTX-3 and sCD40L in patients with coronary heart disease and angina pectoris[J].,2022,(8):644.[doi:DOI:10.3969/j.issn.1000-7369.2022.05.024]
[10]杨春昆,李 军.基于“气主固摄”理论探讨补气药减轻心室重构的生物学基础[J].陕西中医,2022,(12):1816.[doi:DOI:10.3969/j.issn.1000-7369.2022.12.041]
　YANG Chunkun,LI Jun.Biological basis of Qi tonifying drugs to reduce ventricular remodeling based on the theory of Qizhu Gushe[J].,2022,(8):1816.[doi:DOI:10.3969/j.issn.1000-7369.2022.12.041]

备注/Memo

备注/Memo:
基金项目:陕西省重点研发计划一般项目(2020SF-322)
更新日期/Last Update: 2021-08-09